Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
How Tech Enables Environmental Justice at EPA
The agency wants to eliminate bias and establish new tech standards to reduce greenhouse gas emissions.
39m listen -
Building Better Data Governance Across FDA
The agency is using emerging technology to tackle its data challenges.
19m listen -
Coast Guard Poised for Growth in Cyber
The service’s prevention policy chief discusses his priorities for combatting cyber incidents that could have global impacts.
23m listen -
How VA is Using Digital Services to Expand Care to Veterans
CIO Kurt DelBene says the the agency’s 2024 priorities included AI adoption, hiring and a better user experience for veterans.
30m listen